Evidence map›Paper›PMID 39312550›Full record

ArticlePloS one2024

Synergetic inhibitory effect of isopropyl methylphenol-based agents on biofilm formation by Streptococcus mutans.

Arisu Korenaga, Toshiki Miyaoka, Harumi Asami, Yasushi Yamagami, Miki Yoshii, Shigemitsu Tanaka, Toshihiro Nagao

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arisu KorenagaResearch & Development division, Osaka kasei Co., Ltd., Osaka, Japan.ORCID 0009-0006-0809-8745
Toshiki MiyaokaResearch & Development division, Osaka kasei Co., Ltd., Osaka, Japan.
Harumi AsamiResearch & Development division, Osaka kasei Co., Ltd., Osaka, Japan.
Yasushi YamagamiResearch & Development division, Osaka kasei Co., Ltd., Osaka, Japan.
Miki YoshiiResearch Division of Biomaterials and Commodity Chemicals, Osaka Research Institute of Industrial Science and Technology, Osaka, Japan.
Shigemitsu TanakaResearch Division of Biomaterials and Commodity Chemicals, Osaka Research Institute of Industrial Science and Technology, Osaka, Japan.ORCID 0009-0007-0884-1233
Toshihiro NagaoResearch Division of Biomaterials and Commodity Chemicals, Osaka Research Institute of Industrial Science and Technology, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dental caries and periodontitis are the most common oral diseases in humans and the main causes of tooth loss. Streptococcus mutans is primarily responsible for dental caries and dental plaque, which are triggered by biofilm formation on the tooth surface. In this study, biofilm inhibition by 4-isopropyl-3-methylphenol (IPMP)-based agents, consisting of IPMP and polyoxyethylene-hydrogenated castor oil (POEHCO), was investigated in vitro. Notably, the use of POEHCO in addition to IPMP inhibited S. mutans biofilms more drastically than IPMP alone. Moreover, the effects of IPMP on the expression of biofilm-related genes (gtfB, gtfC, and gtfD) were examined using quantitative real-time PCR. IPMP at sub-minimum inhibitory concentrations significantly downregulated the expression of these genes. These results suggested that the inhibitory effects on biofilm formation were synergistically enhanced by the surfactant and antibiofilm activities of IPMP. Therefore, IPMP-based agents as dentifrices may be useful to prevent oral diseases originating from biofilms.

Indexed as

BiofilmsStreptococcus mutansAnti-Bacterial AgentsCastor OilDrug SynergismGene Expression Regulation, BacterialHumansMicrobial Sensitivity TestsPhenolsPolyethylene GlycolsAnti-Bacterial AgentsCastor OilPhenolsPolyethylene Glycols

Identifiers

PMID39312550
PMCPMC11419349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.